Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

NCT00006246 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Childhood Germ Cell Tumor
Leukemia
Lymphoma
Metastatic Cancer
Retinoblastoma
Sarcoma

Interventions

DRUG: busulfan

Sponsor

Pediatric Brain Tumor Consortium

Collaborators

[object Object]